Episode Details
Welcome back to Action Potential, join us this week as we welcome Dr. Jeff Wessler, CEO of Heartbeat Health as we explore and discover the future of cardiology.
What you’ll get from this episode:
- Dr. Jeff Wessler discusses the transformative role of telemedicine in cardiology.
- Insights on Heartbeat Health’s approach to remote patient care.
- The impact of COVID-19 on healthcare technology and patient experiences.
- Future trends in cardiology and healthcare technology.
Watch
Listen
Read
Transforming Healthcare in the Post-COVID Era
The latest episode of our podcast features an enlightening conversation with Dr. Jeff Wessler, CEO of Heartbeat Health. Dr. Wessler shares his expert insights on the evolving landscape of cardiology, especially in the wake of the COVID-19 pandemic.
The Rise of Telemedicine and Heartbeat Health
Discover how Heartbeat Health has embraced telemedicine to revolutionize cardiology care. Dr. Wessler discusses the shift from traditional in-person consultations to a more virtual approach, highlighting the benefits and efficiencies of remote care.
Innovations in Remote Physiological Monitoring
Learn about the cutting-edge technologies being employed in cardiology. Dr. Wessler talks about wearable devices and remote monitoring tools that are transforming patient care, making cardiovascular health management more proactive and accessible.
Economic Implications and Patient-Centric Care
Understand the economic aspects of telemedicine and remote care programs. Dr. Wessler delves into how these innovations not only enhance patient care but also offer cost-effective solutions for healthcare providers.
The Future of Cardiology and Health Tech
Get a glimpse into the future of cardiology and health technology as Dr. Wessler shares his predictions and aspirations. He emphasizes the need for a holistic approach to patient care, integrating cardiology with other health disciplines.
Thank you to our sponsor ProtonIntel!
Hyperkalemia (high potassium) affects more than 3.7M Americans. Chronic Kidney Disease is the main cause & heart attacks are the main effect. For people at risk of hyperkalemia, potassium needs to be tightly monitored, even during treatment.
Today, there is no on-demand K+ monitoring capability to guide treatment of hyperkalemia.
ProtonIntel is building the first real-time, on-demand potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely.
To learn more about Dr. Jeffery Wessler:
– Their LinkedIn – Company Website –
Also, be sure to follow Slice of Healthcare on our social channels:
– Website – LinkedIn – Twitter – YouTube – Newsletter –
